UK clinical trials - updated daily from ClinicalTrials.gov
Understand the key differences between pancreatic cancer and colorectal cancer clinical trials and research opportunities
~10,500 new UK cases annually with poor survival rates. Trials focus on early detection, neoadjuvant approaches, and novel drug combinations.
The fourth most common UK cancer. Biomarker-driven treatment (MSI-H, BRAF, RAS) is increasingly guiding trial eligibility.
Pancreatic cancer has fewer trials due to poor prognosis and difficulty in early detection. Colorectal cancer has more biomarker-defined treatment pathways.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.
